/PRNewswire/ Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of.
Lobe Sciences, Ltd Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED), which is focused on developing psychedelic-derived medicines for neurologic disease, revealed that it has signed.